- Home
- VPG vs ATAI Comparison
VPG vs ATAI Comparison
Compare VPG & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VPG
- ATAI
- Stock Information
- Founded
- VPG 2009
- ATAI 2018
- Country
- VPG United States
- ATAI Germany
- Employees
- VPG N/A
- ATAI N/A
- Industry
- VPG Electrical Products
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- VPG Technology
- ATAI Health Care
- Exchange
- VPG Nasdaq
- ATAI Nasdaq
- Market Cap
- VPG 268.9M
- ATAI 282.6M
- IPO Year
- VPG N/A
- ATAI 2021
- Fundamental
- Price
- VPG $24.28
- ATAI $1.41
- Analyst Decision
- VPG Hold
- ATAI Strong Buy
- Analyst Count
- VPG 1
- ATAI 3
- Target Price
- VPG $31.00
- ATAI $10.50
- AVG Volume (30 Days)
- VPG 215.2K
- ATAI 1.4M
- Earning Date
- VPG 05-06-2025
- ATAI 05-19-2025
- Dividend Yield
- VPG N/A
- ATAI N/A
- EPS Growth
- VPG N/A
- ATAI N/A
- EPS
- VPG 0.23
- ATAI N/A
- Revenue
- VPG $297,480,000.00
- ATAI $308,000.00
- Revenue This Year
- VPG $2.60
- ATAI $65.58
- Revenue Next Year
- VPG $6.04
- ATAI N/A
- P/E Ratio
- VPG $100.05
- ATAI N/A
- Revenue Growth
- VPG N/A
- ATAI N/A
- 52 Week Low
- VPG $18.57
- ATAI $1.03
- 52 Week High
- VPG $35.11
- ATAI $2.57
- Technical
- Relative Strength Index (RSI)
- VPG 54.37
- ATAI 44.57
- Support Level
- VPG $22.66
- ATAI $1.36
- Resistance Level
- VPG $26.52
- ATAI $1.54
- Average True Range (ATR)
- VPG 1.88
- ATAI 0.09
- MACD
- VPG 0.25
- ATAI -0.00
- Stochastic Oscillator
- VPG 67.11
- ATAI 0.00
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.